AbbVie Skyrizi Solution for Injection 600mg 10ml Vial

Skyrizi (risankizumab) is an advanced interleukin-23 (IL-23) antagonist designed to help manage moderate to severe conditions. This injectable therapy provides targeted relief for adults suffering from plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn’s disease or ulcerative colitis. As a biological treatment, it works by selectively blocking specific proteins that contribute to inflammation. This vial format ensures precise administration for those undergoing prescribed systemic therapy or phototherapy. Please consult your healthcare provider to determine if this treatment is appropriate for your specific health needs.

Brand: AbbVie
Active Ingredient: Risankizumab
Drug Class: IL-23 Antagonist
Dosage: 600mg/10ml
Form: Solution for Injection
Indications: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis
Packaging: 1 Vial